Shaheenah Dawood, Consultant Medical Oncologist at Mediclinic Middle East, shared a post on LinkedIn:
“I absolutely love this!
New NCCN guidelines: ADCs are now listed as a first-line option in mTNBC, even before FDA approval.”
More posts featuring Shaheenah Dawood.